Brahim, Lucia Regina;
Valete-Rosalino, Cláudia Maria;
Antônio, Liliane de Fátima;
Pimentel, Maria Inês Fernandes;
Lyra, Marcelo Rosandiski;
Paes, Luiz Eduardo de Carvalho;
Costa, Ananda Dutra da;
Vieira, Iracema Forni;
Dias, Cristina Maria Giordano;
Duque, Maria Cristina de Oliveira;
Marzochi, Mauro Celio de Almeida;
Schubach, Armando de Oliveira.
BACKGROUND American tegumentary leishmaniasis (ATL) is a non-lethal parasitic disease that presents with cutaneous (CL) and mucosal (ML) clinical forms. ATL treatment aims at healing the lesions and preventing the development of the late mucosal form. Systemic meglumine antimoniate (MA) therapy with 10-2...
Abstract: Dermoscopy is a non-invasive technique widely used to aid in the characterization and diagnosis of pigmented skin lesions. Recently, it has also been employed for the evaluation of non-pigmented skin tumours, and inflammatory and infectious cutaneous diseases. Although the diagnosis of cutaneou...
La leishmaniosis tegumentaria es una enfermedad desatendida y descontrolada que afecta a sectores sensibles de la población. El IICS, a través de este consultorio especializado, brinda los servicios de establecer el diagnóstico y acompañar el tratamiento de los casos que se presentan, así como de re...
Abstract: Periungual and paronychia-like skin lesions can mimic various diseases, setting up a diagnostic challenge that invariably requires correlation with complementary tests. We report a case of an ulcerated tumor of the nailfold diagnosed as leishmaniasis. Although paronychia-like cutaneous leishman...
Abstract Although New World cutaneous leishmaniasis is not itself a life-threatening disease, its treatment with systemic antimonials can cause toxicity that can be dangerous to some patients. Intralesional meglumine antimoniate provides a viable, less toxic alternative. Herein, we describe an alternativ...
ABSTRACT INTRODUCTION: Cutaneous leishmaniasis (CL) is a tropical disease that affects millions of individuals worldwide. The current drugs for CL may be effective but have serious side effects; hence, alternatives are urgently needed. Although plant-derived materials are used for the treatment of vari...
Antiprotozoarios/farmacología,
Antiprotozoarios/uso terapéutico,
Artemisia annua/química,
Cricetinae,
Leishmania/efectos de los fármacos,
Leishmaniasis Cutánea/tratamiento farmacológico,
Pruebas de Sensibilidad Parasitaria,
Extractos Vegetales/farmacología,
Extractos Vegetales/uso terapéutico,
Hojas de la Planta/química,
Resultado del Tratamiento
Abstract INTRODUCTION: Intralesional treatment for cutaneous leishmaniasis has been applied for over 30 years at the Oswaldo Cruz Foundation, Rio de Janeiro, with good therapeutic results and without relevant systemic toxicity. METHODS Meglumine antimoniate was injected subcutaneously, using a long me...
Abstract INTRODUCTION American tegumentary leishmaniasis (ATL) is an endemic disease in many regions of Brazil; however, only few reports on the actual epidemiological conditions are available. Here, we aimed to assess the clinical, epidemiological, and laboratory characteristics of ATL patients and th...
Abstract: We report an imported case of cutaneous leishmaniasis in a 37-year-old man from Saudi Arabia caused by Leishmania major. He presented with non-healing nodulo-ulcerative lesions with a "volcanic crater" on the lower limbs. It was clearly cutaneous leishmaniasis - a rare disease in China - as ref...
